
Auriga Life Sciences Private Limited
About Auriga Life Sciences Private Limited
Data last updated:
Auriga Life Sciences Private Limited is a private limited company based in Kochi, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2013PTC034650. Its GSTIN is 32AALCA9281F1ZL (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.75 Lakh. It is led by directors including Vinodkumar Madhavan (Managing Director) and Subramonia Iyer Hariharan.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 35/1630 D South Janatha Road Palarivattom Kochi – 682025, Kerala, India – 682025.
As per the financials filed for FY 2019, the company reported a revenue of ₹69.33 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.3 Lakh (net margin 3.3%) and EBITDA of ₹3.22 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Auriga Life Sciences Private Limited's registered office is in Kochi, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address35/1630 D South Janatha Road Palarivattom Kochi – 682025, Kerala, India – 682025
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Auriga Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Auriga Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Auriga Life Sciences Private Limited, buy the company report.
Financials of Auriga Life Sciences Private Limited
FY 2019 filings availableAuriga Life Sciences Private Limited reported revenue of ₹69.33 Lakh (down 2% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹69.33 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Auriga Life Sciences Private Limited, buy the company report.
Board of directors of Auriga Life Sciences Private Limited
Auriga Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subramonia Iyer Hariharan | Director | 30 Jul 2013 | 13 Years 3 Months | Current |
| Vinodkumar Madhavan | Managing Director | 30 Jul 2013 | 13 Years 3 Months | Current |
| Ramadil Suresh Unni | Additional Director | 02 Sep 2021 | 5 Years 2 Months | Current |
| Binu Varghese | Additional Director | 02 Sep 2021 | 5 Years 2 Months | Current |
Peer comparison
Auriga Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neutron Medicals Private Limited | ₹69.44 Lakh (FY 2020) | 64.0% | Pune, Maharashtra, India | |||
| Auriga Life Sciences Private Limitedthis company | ₹69.33 Lakh (FY 2019) | ₹2.3 Lakh | 3.3% | -2.0% | Kochi, Kerala, India | |
| Medcorpus Pharmaceuticals Private Limited | ₹69.28 Lakh (FY 2025) | 4.0% | Kolathur, Tamil Nadu, India | |||
| Caprice Healthcare Private Limited | ₹69.19 Lakh (FY 2025) | -15.0% | Ernakulam, Kerala, India | |||
| Amazon Drugs Private Limited | ₹68.9 Lakh (FY 2025) | -24.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Auriga Life Sciences Private Limited, buy the company report.
Auditor
Auriga Life Sciences Private Limited is audited by PRASHANT MOHAN & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASHANT MOHAN & ASSOCIATES | FY 2019 | 016470S |
Shareholding
The shareholding of Auriga Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Auriga Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Auriga Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Auriga Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Auriga Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AALCA9281F1ZL | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Auriga Life Sciences Private Limited, buy the company report.
Recent activity
Auriga Life Sciences Private Limited has 5 board changes on record since 2013: 4 appointments and 1 cessation. The latest: Binu Varghese was appointed as Additional Director on 02 Sep 2021.
Frequently asked questions
Auriga Life Sciences is an active private limited company based in Kochi, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 July 2013 (13+ years old) and is registered under CIN U24232KL2013PTC034650.
Auriga Life Sciences has 4 current directors:
- Vinodkumar Madhavan - Managing Director
- Subramonia Iyer Hariharan - Director
- Ramadil Suresh Unni - Additional Director
- Binu Varghese - Additional Director
The latest financial statements of Auriga Life Sciences on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Auriga Life Sciences is 32AALCA9281F1ZL, registered in Kerala.
The CIN (Corporate Identification Number) of Auriga Life Sciences is U24232KL2013PTC034650. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auriga Life Sciences was incorporated on 30 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Auriga Life Sciences by revenue are Neutron Medicals Private Limited, Medcorpus Pharmaceuticals Private Limited, Caprice Healthcare Private Limited, Amazon Drugs Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Binu Varghese was appointed as Additional Director on 02 Sep 2021. Ramadil Suresh Unni was appointed as Additional Director on 02 Sep 2021. Nithin Raj Rajendran ceased to be Director on 28 Aug 2018. Auriga Life Sciences has 5 board changes on record in total.
The registered office of Auriga Life Sciences is at 351630 D South Janatha Road Palarivattom Kochi – 682025, Kerala, India – 682025.
Auriga Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Auriga Life Sciences is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.

